SlideShare una empresa de Scribd logo
1 de 23
RABIES VACCINE
RABIES VACCINE



  By:
  J.S.K. NAGARAJAN,
  ASST. PROFESSOR,
  JSS UNIVERSITY,
  (OFF CAMPUS, JSS COLLEGE OF PHARMACY),
  OOTY- 643 001.
  E-mail: nagasaki2001@rediffmail.com
  Ph: 09443149945
Rabies       -Introduction

• Viral disease - cause acute encephalitis (inflammation of the
  brain) in warm-blooded animals.
• Zoonotic (animals to humans).
• Bite from an infected animal.
• For a human, rabies is almost invariably fatal if post-exposure
  prophylaxis is not administered prior to the onset of severe
  symptoms.
• Virus infects the CNS, cause disease in the brain & death.
• Causative Organism – Lyssavirus genus(Family Rhabdoviridae)
Longitudinal Section of Rabies Virus
Sequential Steps of Rabies Transmission
Virus lifestyle
• Virus replicated in muscle cells near site of bite for most of
  incubation time.
   – Incubation time 30-90 days.

• Then ascends along motor and sensory axons at rate of 12-
  100mm/day and has predilection for brainstem and medulla

• Enters salivary glands after replication in CNS.
Animal Behavior
• Classic Picture of rabid, mangy dog foaming at the
  mouth…not often seen, signs frequently more subtle.

• Animals - display aggressive behavior, ataxia, irritability,
  anorexia, lethargy/excessive salivation.

• Cats are more likely to be aggressive than dogs

• Animals exhibit change in instinctive behavior: nocturnal
  animal walking around in daylight (i.e. raccoons)
• Unprovoked bites
Transmission



• Almost all transmission is by bite
• 50 times greater risk than a scratch
• One human case may have been acquired in a
  laboratory transmitted by aerosol
• In wild animals: Rabies can be transmitted
  transplacentally
• Transplants in human- possible
• Human-to-human: Never has been confirmed
• Rabies virus never isolated from blood
Rabies virus

• Risk of developing rabies after a bite: 5-80%.
  – Depends upon….
     •   Severity of exposure
     •   Location of the bite
     •   The biting animal
     •   Bites on head and neck have shorter incubation time
         (as short as 15 days) because of rich peripheral nerve
         supply
Encephalitic Form


• Hydrophobia: Patient can’t swallow because violent jerky contraction of
  diaphragm and accessory muscles of inspiration when pt attempts to
  swallow liquids
       - Patients will be terrified during this reaction and may even
  experience this at the sight of water or if water touches their face.

• Aerophobia: an extreme fear of air in motion can be elicited from some
  patients. This can also cause violent muscle spasms in the neck and
  pharynx.
• Hallucinations, seizures, ataxia, focal weakness and arrhythmias can
  occur.
Paralytic Rabies


• Other form is “dumb” or paralytic rabies. Similar
  to Guillain-Barre.
   – Prominent limb weakness. Consciousness
     initially spared
• Two forms can overlap or progress from one to the
  other
• Coma after one week of neuro symptoms with
  death a few days after.
Rabies vaccine
PRINCIPLE:
     Potency of rabies vaccine is determined by
  comparing a lethal intra-cerebral dose of a
  rabies virus with the dose of the standard
  preparation of rabies vaccines necessary to
  give for same protection.
Rabies Vaccine Assay
Test Animals:
Mice – 3 -4 weeks old
11 – 15 gm
 6 X 16 and 4 X 10


                        Calculate LD 50 For Virus suspension




                        Estimation Of Potency
Preparation of Standard Challenge Virus Suspension:
             Inject the Virus (0.3ml of 10 fold diln. -Intra Cerebrally)

                       Sacrifice the animal(after getting signs)

                                Harvest the brain aseptically

                   Wash with saline to remove blood clots
      Method 1                                         Method 2
 10% suspension brain homogenised Brain homogenised with diluent
                                        gives 10% suspension

                  Centrifuge lightly & collect the supernatant liquid

Distribute into sterile vials                Distribute in sterile ampoules/vials

Freeze dry and store @ -200 C                 Store @ -600 C ( maintain NLT 1 Yr.)
(maintain for NLT 3yrs)
Rabies Vaccine Assay
Virus Tire of the Challenge Virus:

        Prepare 3-10 fold dilution of std.challenge virus suspension.
                                          ↓
                  0.03ml inject intracerebrally to 4 X 10 mice.
                                          ↓
                            Observe mice for 14 days.
                                           ↓
              Count the number of mice surviving in each group.
                                           ↓
    Calculate the virus titre of std challenge vurus suspension by statistical
                                      method.


Determination of Potency:

Potency of rabies vaccine is determined by comparing the dose necessary to
protect mice against a lethal intracerebral dose of rabies vaccine necessary to
provide the same protection.
Rabies Vaccine Assay cont’n
 Prepare 3-5 fold serial dilution of standard and test soln of vaccines

                 Separate mice in 6 groups of 16each

              Inject the vaccine 0.03ml(Intra-Peritoneal)

                     After 7 days inject the same

After further 7 days inject 0.03ml Standard challenge virus suspension
                             by 5 to 50 LD50

       Observe for 14 days and record the number of survivals

   Calculate the potency of the preparation under examination by
                    standard statistical methods.
RABIES ANTI SERUM
• Rabies anti serum is a preparation containing the specific
   globulin [or] its derivatives obtaines by purification of hyper
   immune serum[or] plasma of healthy horses [or] other
   animals having the specific activity of neutralizing the
   rabies virus.
• BIOLOGICAL ASSAY OF RABIES ANTISERUM:
        The potency of rabies antiserum is determined by
comparing a lethal intracerebral dose of rabies virus with the
dose of standard preparation of rabies antiserum necessary to
give same protection.
PROCEDURE:
STANDARD PREPARATION:
Standard preparation is dried serum (or)
Other preparation , the potency of which has been
     determined in relation to international standard.
TEST ANIMALS:
Mice, 10g-14g-animal same sex.
TEST VIRUS:
Any suitable strain rabies virus of known potency, such as the
     CVS strain may be used.
TEST DOSE OF VIRUS:
20-1000 LD50 intracerebral injection to each mouse.
DET. OF TEST DOSE OF VIRUS:
    Virus dilutionequal quantity of 2%v/v solution of heat
                  inactivated horse serum in water .
                                     ↓
                  Maintain at 37⁰c at one hour.

      2) Prepare is 10 fold dilution in a 2%v/v solution of heat –
                    inactivated normal horse serum
                         Inject into mouse.
                                      ↓
    The test is not valid unless the quantity of virus used lies
                        between 20-1000 LD50.
DETERMINATION POTENCY OF RABIES
  ANTISERUM:

Prepare 2 fold dilution of std preparation and test
     preparation with 2% v/v heat inactivated
            normal horse serum in water.
                         ↓
To each dilution add a quantity of suspension of
                      test virus
                         ↓
           Keep the mix at 37⁰c for 1hr
                         ↓
      Inject 0.03ml intracerebrally to mice
                         ↓
Observe mice for 14days
                                  ↓
Mice dying before 5th day after inoculation of virus are eliminate
     from test, all the mice dying between 5th -14th day after
                        showing signs of rabies
                                 ↓
                  Count the no of mice surviving
                                 ↓
        Calculate potency of the test preparation by std
                          statisticalmethod

         – The preparation pass the test it found to have 80units /ml
            – The preparation for the test also same as standard
Rabies Vaccine Assay cont’n
Vaccine complies with the test if the estimated potency
is NLT 2.5 IU/single dose.

- The test is not valid unless
(a) for both the ppn under examination and the std
    ppn, the 50% protective dose lies between the
    largest and smallest doses given to the mice;

(b) there is not deviation from linearity or parallelism of
the dose response lines, the confidence limit (P= 0.95)
are NLT 25% & NMT 400% of the estimated potency;

(c) the titre of the challenge virus suspension lies
between 5 to 50 LD50.
Rabies   jsk nagarajan

Más contenido relacionado

La actualidad más candente

Rabies main prabhat
Rabies main prabhatRabies main prabhat
Rabies main prabhatdarktranq
 
"One Health in the Prevention and Control of Rabies"
 "One Health in the Prevention and Control of Rabies" "One Health in the Prevention and Control of Rabies"
"One Health in the Prevention and Control of Rabies"Abraham_Kidane
 
Post exposure prophylaxis in Rabies
Post exposure prophylaxis in RabiesPost exposure prophylaxis in Rabies
Post exposure prophylaxis in RabiesDrVijay Singh
 
19629 lec 12 arboviruses medical virology
19629 lec 12 arboviruses medical virology19629 lec 12 arboviruses medical virology
19629 lec 12 arboviruses medical virologyatulkhandagle1
 
Prevention and control of rabies
Prevention and control of rabiesPrevention and control of rabies
Prevention and control of rabiesMohit kadyan
 
Rabies vaccine ppt by royal
Rabies vaccine ppt by royalRabies vaccine ppt by royal
Rabies vaccine ppt by royalhusnatazeen
 
Rabies vaccines
Rabies vaccinesRabies vaccines
Rabies vaccinesNagendra P
 
Dr.k yashoda rabies presentation
Dr.k yashoda rabies presentationDr.k yashoda rabies presentation
Dr.k yashoda rabies presentationNAGARAJUALPULA
 
National Guidelines for Rabies Prophylaxis in India
National Guidelines for Rabies Prophylaxis in IndiaNational Guidelines for Rabies Prophylaxis in India
National Guidelines for Rabies Prophylaxis in IndiaDhruvendra Pandey
 
Epidemiology of rabies
Epidemiology of rabiesEpidemiology of rabies
Epidemiology of rabiesNamita Batra
 
Rabies rod prasad
Rabies   rod prasadRabies   rod prasad
Rabies rod prasadrod prasad
 
Rabies: a fatal zoonotic threat
Rabies: a fatal zoonotic threatRabies: a fatal zoonotic threat
Rabies: a fatal zoonotic threatShubhamSaini176
 

La actualidad más candente (20)

Human Rabies
Human RabiesHuman Rabies
Human Rabies
 
Rabis communti
Rabis communtiRabis communti
Rabis communti
 
Rabies main prabhat
Rabies main prabhatRabies main prabhat
Rabies main prabhat
 
"One Health in the Prevention and Control of Rabies"
 "One Health in the Prevention and Control of Rabies" "One Health in the Prevention and Control of Rabies"
"One Health in the Prevention and Control of Rabies"
 
Post exposure prophylaxis in Rabies
Post exposure prophylaxis in RabiesPost exposure prophylaxis in Rabies
Post exposure prophylaxis in Rabies
 
19629 lec 12 arboviruses medical virology
19629 lec 12 arboviruses medical virology19629 lec 12 arboviruses medical virology
19629 lec 12 arboviruses medical virology
 
Rabies ppt
Rabies  pptRabies  ppt
Rabies ppt
 
Prevention and control of rabies
Prevention and control of rabiesPrevention and control of rabies
Prevention and control of rabies
 
Basic rabies-for-dep ed
Basic rabies-for-dep edBasic rabies-for-dep ed
Basic rabies-for-dep ed
 
Rabies vaccine ppt by royal
Rabies vaccine ppt by royalRabies vaccine ppt by royal
Rabies vaccine ppt by royal
 
Rabies vaccines
Rabies vaccinesRabies vaccines
Rabies vaccines
 
Rabies
RabiesRabies
Rabies
 
Dr.k yashoda rabies presentation
Dr.k yashoda rabies presentationDr.k yashoda rabies presentation
Dr.k yashoda rabies presentation
 
Rabies
RabiesRabies
Rabies
 
National Guidelines for Rabies Prophylaxis in India
National Guidelines for Rabies Prophylaxis in IndiaNational Guidelines for Rabies Prophylaxis in India
National Guidelines for Rabies Prophylaxis in India
 
Epidemiology of rabies
Epidemiology of rabiesEpidemiology of rabies
Epidemiology of rabies
 
Rabies Virus - Lyssavirus
Rabies Virus - LyssavirusRabies Virus - Lyssavirus
Rabies Virus - Lyssavirus
 
Rabies rod prasad
Rabies   rod prasadRabies   rod prasad
Rabies rod prasad
 
Rabies
RabiesRabies
Rabies
 
Rabies: a fatal zoonotic threat
Rabies: a fatal zoonotic threatRabies: a fatal zoonotic threat
Rabies: a fatal zoonotic threat
 

Destacado (20)

Measles and medical tyranny
Measles and medical tyrannyMeasles and medical tyranny
Measles and medical tyranny
 
Vaccines
VaccinesVaccines
Vaccines
 
Rabies
RabiesRabies
Rabies
 
Rabies
RabiesRabies
Rabies
 
Rabies
RabiesRabies
Rabies
 
Rabies
Rabies Rabies
Rabies
 
S&H Images
S&H ImagesS&H Images
S&H Images
 
Vaccination update ppt- a asmaaler thing which i made to rebrush myself
Vaccination update ppt- a asmaaler thing which i made to rebrush myself Vaccination update ppt- a asmaaler thing which i made to rebrush myself
Vaccination update ppt- a asmaaler thing which i made to rebrush myself
 
Dog Rabies Symptoms
Dog Rabies SymptomsDog Rabies Symptoms
Dog Rabies Symptoms
 
Rabies
RabiesRabies
Rabies
 
Vaccine Storage And Handling Atkinson
Vaccine Storage And Handling AtkinsonVaccine Storage And Handling Atkinson
Vaccine Storage And Handling Atkinson
 
Tptz final
Tptz finalTptz final
Tptz final
 
Rabies
RabiesRabies
Rabies
 
Pdac,ninhydrin,1,2 naphthoquinone reagents
Pdac,ninhydrin,1,2 naphthoquinone reagentsPdac,ninhydrin,1,2 naphthoquinone reagents
Pdac,ninhydrin,1,2 naphthoquinone reagents
 
Rabies, Rhabdoviridae
Rabies, RhabdoviridaeRabies, Rhabdoviridae
Rabies, Rhabdoviridae
 
Rabies
RabiesRabies
Rabies
 
Rabies
RabiesRabies
Rabies
 
Rabies: information you need to know
Rabies: information you need to knowRabies: information you need to know
Rabies: information you need to know
 
Rabies
RabiesRabies
Rabies
 
Oxytocin final
Oxytocin finalOxytocin final
Oxytocin final
 

Similar a Rabies jsk nagarajan

APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...
APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...
APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...Venkatesan R - 6369851191
 
Assays of Rabies vaccine
Assays of Rabies vaccineAssays of Rabies vaccine
Assays of Rabies vaccineRam Kumar
 
rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS
 rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS
rabies vaccine and tetanus anti serum FOR PHARM ANALYSISprakash64742
 
Rabies ,microbiology
Rabies ,microbiologyRabies ,microbiology
Rabies ,microbiologyLubnaSSubair
 
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...Dr Sujith Chadala
 
Micro biological assay of vaccines
Micro biological assay of vaccinesMicro biological assay of vaccines
Micro biological assay of vaccinessiva ganesh
 
Micro bio(rhebovirus)
Micro bio(rhebovirus)Micro bio(rhebovirus)
Micro bio(rhebovirus)Viju Rathod
 
Rabies: The Most Fatal Disease.pptx
Rabies: The Most Fatal Disease.pptxRabies: The Most Fatal Disease.pptx
Rabies: The Most Fatal Disease.pptxAkhiruzzaman Rakib
 
ABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysis
ABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysisABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysis
ABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysisVenkatesan R - 6369851191
 
Biological test and assay of Absorbed Diphtheria vaccine
Biological test and assay of  Absorbed Diphtheria vaccineBiological test and assay of  Absorbed Diphtheria vaccine
Biological test and assay of Absorbed Diphtheria vaccineUshaKhanal3
 

Similar a Rabies jsk nagarajan (20)

APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...
APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...
APA-RABIES VACCINES pharmceutical analysis m.pharm advanced pharmaceutical an...
 
Assays of Rabies vaccine
Assays of Rabies vaccineAssays of Rabies vaccine
Assays of Rabies vaccine
 
Assays of rabies vaccine
Assays of rabies vaccineAssays of rabies vaccine
Assays of rabies vaccine
 
Rabies Vaccine
Rabies VaccineRabies Vaccine
Rabies Vaccine
 
Microbiological assay of vaccines
Microbiological assay of vaccinesMicrobiological assay of vaccines
Microbiological assay of vaccines
 
rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS
 rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS
rabies vaccine and tetanus anti serum FOR PHARM ANALYSIS
 
Rabies ,microbiology
Rabies ,microbiologyRabies ,microbiology
Rabies ,microbiology
 
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
Rabies Powerpoint Presentation aerophobia, dog bite prophylaxis, hydrophobia,...
 
Micro biological assay of vaccines
Micro biological assay of vaccinesMicro biological assay of vaccines
Micro biological assay of vaccines
 
Rhabdovirus lecture
Rhabdovirus lectureRhabdovirus lecture
Rhabdovirus lecture
 
Rabies
RabiesRabies
Rabies
 
Rabies.pptx
Rabies.pptxRabies.pptx
Rabies.pptx
 
25. rabies virus
25. rabies virus25. rabies virus
25. rabies virus
 
Rabies 1234
Rabies 1234Rabies 1234
Rabies 1234
 
RABIES
RABIES RABIES
RABIES
 
Rabies ppt
Rabies pptRabies ppt
Rabies ppt
 
Micro bio(rhebovirus)
Micro bio(rhebovirus)Micro bio(rhebovirus)
Micro bio(rhebovirus)
 
Rabies: The Most Fatal Disease.pptx
Rabies: The Most Fatal Disease.pptxRabies: The Most Fatal Disease.pptx
Rabies: The Most Fatal Disease.pptx
 
ABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysis
ABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysisABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysis
ABHISHEK S2 APA ANTI- VENOM advanced pharmaceutical analysis
 
Biological test and assay of Absorbed Diphtheria vaccine
Biological test and assay of  Absorbed Diphtheria vaccineBiological test and assay of  Absorbed Diphtheria vaccine
Biological test and assay of Absorbed Diphtheria vaccine
 

Rabies jsk nagarajan

  • 2. RABIES VACCINE By: J.S.K. NAGARAJAN, ASST. PROFESSOR, JSS UNIVERSITY, (OFF CAMPUS, JSS COLLEGE OF PHARMACY), OOTY- 643 001. E-mail: nagasaki2001@rediffmail.com Ph: 09443149945
  • 3. Rabies -Introduction • Viral disease - cause acute encephalitis (inflammation of the brain) in warm-blooded animals. • Zoonotic (animals to humans). • Bite from an infected animal. • For a human, rabies is almost invariably fatal if post-exposure prophylaxis is not administered prior to the onset of severe symptoms. • Virus infects the CNS, cause disease in the brain & death. • Causative Organism – Lyssavirus genus(Family Rhabdoviridae)
  • 4. Longitudinal Section of Rabies Virus
  • 5. Sequential Steps of Rabies Transmission
  • 6. Virus lifestyle • Virus replicated in muscle cells near site of bite for most of incubation time. – Incubation time 30-90 days. • Then ascends along motor and sensory axons at rate of 12- 100mm/day and has predilection for brainstem and medulla • Enters salivary glands after replication in CNS.
  • 7. Animal Behavior • Classic Picture of rabid, mangy dog foaming at the mouth…not often seen, signs frequently more subtle. • Animals - display aggressive behavior, ataxia, irritability, anorexia, lethargy/excessive salivation. • Cats are more likely to be aggressive than dogs • Animals exhibit change in instinctive behavior: nocturnal animal walking around in daylight (i.e. raccoons) • Unprovoked bites
  • 8. Transmission • Almost all transmission is by bite • 50 times greater risk than a scratch • One human case may have been acquired in a laboratory transmitted by aerosol • In wild animals: Rabies can be transmitted transplacentally • Transplants in human- possible • Human-to-human: Never has been confirmed • Rabies virus never isolated from blood
  • 9. Rabies virus • Risk of developing rabies after a bite: 5-80%. – Depends upon…. • Severity of exposure • Location of the bite • The biting animal • Bites on head and neck have shorter incubation time (as short as 15 days) because of rich peripheral nerve supply
  • 10. Encephalitic Form • Hydrophobia: Patient can’t swallow because violent jerky contraction of diaphragm and accessory muscles of inspiration when pt attempts to swallow liquids - Patients will be terrified during this reaction and may even experience this at the sight of water or if water touches their face. • Aerophobia: an extreme fear of air in motion can be elicited from some patients. This can also cause violent muscle spasms in the neck and pharynx. • Hallucinations, seizures, ataxia, focal weakness and arrhythmias can occur.
  • 11. Paralytic Rabies • Other form is “dumb” or paralytic rabies. Similar to Guillain-Barre. – Prominent limb weakness. Consciousness initially spared • Two forms can overlap or progress from one to the other • Coma after one week of neuro symptoms with death a few days after.
  • 12. Rabies vaccine PRINCIPLE: Potency of rabies vaccine is determined by comparing a lethal intra-cerebral dose of a rabies virus with the dose of the standard preparation of rabies vaccines necessary to give for same protection.
  • 13. Rabies Vaccine Assay Test Animals: Mice – 3 -4 weeks old 11 – 15 gm 6 X 16 and 4 X 10 Calculate LD 50 For Virus suspension Estimation Of Potency
  • 14. Preparation of Standard Challenge Virus Suspension: Inject the Virus (0.3ml of 10 fold diln. -Intra Cerebrally) Sacrifice the animal(after getting signs) Harvest the brain aseptically Wash with saline to remove blood clots Method 1 Method 2 10% suspension brain homogenised Brain homogenised with diluent gives 10% suspension Centrifuge lightly & collect the supernatant liquid Distribute into sterile vials Distribute in sterile ampoules/vials Freeze dry and store @ -200 C Store @ -600 C ( maintain NLT 1 Yr.) (maintain for NLT 3yrs)
  • 15. Rabies Vaccine Assay Virus Tire of the Challenge Virus: Prepare 3-10 fold dilution of std.challenge virus suspension. ↓ 0.03ml inject intracerebrally to 4 X 10 mice. ↓ Observe mice for 14 days. ↓ Count the number of mice surviving in each group. ↓ Calculate the virus titre of std challenge vurus suspension by statistical method. Determination of Potency: Potency of rabies vaccine is determined by comparing the dose necessary to protect mice against a lethal intracerebral dose of rabies vaccine necessary to provide the same protection.
  • 16. Rabies Vaccine Assay cont’n Prepare 3-5 fold serial dilution of standard and test soln of vaccines Separate mice in 6 groups of 16each Inject the vaccine 0.03ml(Intra-Peritoneal) After 7 days inject the same After further 7 days inject 0.03ml Standard challenge virus suspension by 5 to 50 LD50 Observe for 14 days and record the number of survivals Calculate the potency of the preparation under examination by standard statistical methods.
  • 17. RABIES ANTI SERUM • Rabies anti serum is a preparation containing the specific globulin [or] its derivatives obtaines by purification of hyper immune serum[or] plasma of healthy horses [or] other animals having the specific activity of neutralizing the rabies virus. • BIOLOGICAL ASSAY OF RABIES ANTISERUM: The potency of rabies antiserum is determined by comparing a lethal intracerebral dose of rabies virus with the dose of standard preparation of rabies antiserum necessary to give same protection.
  • 18. PROCEDURE: STANDARD PREPARATION: Standard preparation is dried serum (or) Other preparation , the potency of which has been determined in relation to international standard. TEST ANIMALS: Mice, 10g-14g-animal same sex. TEST VIRUS: Any suitable strain rabies virus of known potency, such as the CVS strain may be used. TEST DOSE OF VIRUS: 20-1000 LD50 intracerebral injection to each mouse.
  • 19. DET. OF TEST DOSE OF VIRUS: Virus dilutionequal quantity of 2%v/v solution of heat inactivated horse serum in water . ↓ Maintain at 37⁰c at one hour. 2) Prepare is 10 fold dilution in a 2%v/v solution of heat – inactivated normal horse serum Inject into mouse. ↓ The test is not valid unless the quantity of virus used lies between 20-1000 LD50.
  • 20. DETERMINATION POTENCY OF RABIES ANTISERUM: Prepare 2 fold dilution of std preparation and test preparation with 2% v/v heat inactivated normal horse serum in water. ↓ To each dilution add a quantity of suspension of test virus ↓ Keep the mix at 37⁰c for 1hr ↓ Inject 0.03ml intracerebrally to mice ↓
  • 21. Observe mice for 14days ↓ Mice dying before 5th day after inoculation of virus are eliminate from test, all the mice dying between 5th -14th day after showing signs of rabies ↓ Count the no of mice surviving ↓ Calculate potency of the test preparation by std statisticalmethod – The preparation pass the test it found to have 80units /ml – The preparation for the test also same as standard
  • 22. Rabies Vaccine Assay cont’n Vaccine complies with the test if the estimated potency is NLT 2.5 IU/single dose. - The test is not valid unless (a) for both the ppn under examination and the std ppn, the 50% protective dose lies between the largest and smallest doses given to the mice; (b) there is not deviation from linearity or parallelism of the dose response lines, the confidence limit (P= 0.95) are NLT 25% & NMT 400% of the estimated potency; (c) the titre of the challenge virus suspension lies between 5 to 50 LD50.